Arvinas
ID: 5291127A pharmaceutical company developing protein degradation drugs to treat cancer and other diseases
3
Funding Rounds
$111.6m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Cr*** M. Cr*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** G. Ho***** | - | - | |
| Ti***** Sh***** | - | - | - |
| Li** Ra******* | - | - | - |
Funding series
Funding Series Analysis
The company Arvinas has raised a total of $15m in funding over 3 rounds.
Key Insights:
- Arvinas Series A round: $15m
- Arvinas Series B round, October 2015: $41.6m
- Arvinas Therapeutics funding round, April 2018: $55m
Industries
Arvinas is active in the following industries: